Though the excitement is on Canada right now, we can’t forget that the US market is still in its “early stages”. Better yet is that the 2018 Farm Bill has officially be signed in by the President of the United States; a pivotal decision that could be a huge catalyst for US marijuana stocks. One […]
One Marijuana Stock Aiming To Dominate The US Market Earlier this year we began to focus on Next Green Wave (NXGWF) (NGW) and if you notice something different, you’re right! For the last few months, Next Green Wave has only traded on the Canadian exchanges, limiting access from the major US markets but NOW that […]
Following up from the previous article, Another Win For Marijuana Stocks: Farm Bill Passes House & Moves Onto The President, President Donald Trump officially signed the 2018 US Farm Bill into law at 4:01pm on Thursday, December 20th. The new bill will officially make industrial hemp land hemp-based CBD legal across all 50 states effective […]
Ryan Allway December 21st, 2018 FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) in response to Therapix Biosciences’ termination of the company’s binding letter of intent (LOI) to be acquired by FSD Pharma, Dr. Raza Bokhari, Executive Co-Chairman of the Board of FSD... Read more
Ryan Allway December 20th, 2018 Uncategorized Gabriella’s Kitchen (CSE: GABY) appears to be on the leading edge to service both mainstream grocery and cannabis distribution channels with CBD infused products, as well as CBD and THC-infused edible and wellness products throughout Canada and the U.S. Positioned to be... Read more
Ryan Allway December 20th, 2018 Uncategorized Canada’s cannabis industry may be rapidly growing with new initial public offerings each week, but there has also been a fair share of consolidation within the industry. Investors may want to take a closer look at industry mergers, since they have the... Read more
Ryan Allway December 20th, 2018 Uncategorized Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for... Read more
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
Latest News From This Cannabis Company Could Mean A Big Leg Up On Industry Leaders We’re all aware of the biggest names in the cannabis industry right now. Companies like Canopy Growth, Aphria, Tilray, Cronos Group, and Aurora Cannabis are all mentioned when we see reports about “Market Leaders” in marijuana. The interesting part: there […]
“While Mojave Jane’s production delivers revenue and cash flow to the Company, it also means realizing the advantages of integrating with High Hampton’s complete portfolio”, commented Gary Latham, High Hampton’s CEO. “That is where the real long term value of this company will be realized.” About Mojave Jane LLC.... Read more